Tobacco: Science, policy and public health

Tobacco: Science, Policy and Public Health Second Edition comprehensively covers the science and policy issues relevant to one of the major public health disasters of modern times. It pulls together the aetiology and burden of the myriad of tobacco-related diseases with the successes and failures of tobacco control policies. The book looks at lessons learnt to help set health policy for reducing the burden of tobacco-related diseases. It also deals with the international public health policy issues which bear on control of the problem of tobacco use and which vary between continents.

New chapters in this second edition include: Market manipulation: How the tobacco industry recruits and retains smokers; In Their Own Words: An Epoch of Deceit and Deception; Manipulating Product Design to Reinforce Tobacco Addiction; and a new section of the text devoted to 'Tobacco around the world'.

The editors are an international group distinguished in the field of tobacco-related diseases, epidemiology, and tobacco control. The contributors are world experts drawn from the various clinical fields. This major reference text gives a unique overview of one of the major public health problems in both the developed and developing world.


Readership: Those involved in public health and epidemiology, including policy makers and health economists, addiction scientists and clinicians.


Edited by Peter Boyle, Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy, Nigel Gray, Honorary Senior Associate, Cancer Council Victoria, Australia, Jack Henningfield, Professor, Behavioral Biology and Director, Innovators Awards Program, Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine and Vice President, Research and Health Policy, Pinney Associates, USA, John Seffrin, Chief Executive Officer, American Cancer Society, Inc, USA, and Witold Zatonski, Director and Professor in the Division of Epidemiology and Cancer Prevention Center and Institute of Oncology; Founder and President of the Health Promotion Foundation, Warsaw, Poland





Contributors:
C. Everett Koop, Senior Scholar, C. Everett Koop Institute, Dartmouth College, Hanover, USA
Richard Doll, Clinical Trial Service Unit & Epidemiological Studies Unit, Radcliffe Infirmary, Oxford, UK
Michael J. Thun, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, USA
S. J. Henley, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, USA
Lynn T. Kozlowski, Department of Biobehavioral Health, Penn State University, USA
Richard J. O'Connor, Department of Biobehavioral Health, Penn State University, USA
Melanie Wakefield, Director and NHMRC Principal Research Fellow, Centre for Behavioural Research in Cancer, The Cancer Council Victoria, Australia
Channing Robertson, Ruth G. and William K. Bowes Professor in the School of Engineering, Department of Chemical Engineering, Stanford University, USA
Richard Hurt, Professor of Medicine, Mayo Clinic Nicotine Dependence Center, Mayo Clinic, Rochester, USA
Dietrich Hoffmann, American Health Foundation, New York, USA
Ilse Hoffmann, American Health Foundation, New York, USA
Stephen S. Hecht, Masonic Cancer Center, University of Minnesota, USA
Jack E. Henningfield, Johns Hopkins University School of Medicine, and Pinney Associates, Maryland, USA
Neal L. Benowitz, University of California, San Francisco, USA
Geoffrey Ferris Wayne, MA, Harvard School of Public Health, Division of Public Health Practice, Boston, USA
Carrie M. Carpenter, Harvard School of Public Health, Division of Public Health Practice, Boston, USA
Mirjana V. Djordjevic, Tobacco Control Research Branch, Behavioral Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, USA
Witold Zatonski, Director and Professor in the Division of Epidemiology and Cancer Prevention, Center and Institute of Oncology; Founder and President of the Health Promotion Foundation, Warsaw, Poland
Marta Manczuk, Division of Epidemiology and Cancer Prevention, Center and Institute of Oncology, Warsaw, Poland
Prakash C. Gupta, Director, Healis - Sekhsaria Institute for Public Health, Mumbai, India
Cecily S. Ray, Research Fellow, Healis - Sekhsaria Institute for Public Health, Mumbai, India
Jae-Gahb Park, Cancer Research Institute and Cancer Research Center, Seoul National University, Korea
Ji Won Park, Research Institute and Hospital, National Cancer Center, Goyang, Korea
Hong-Gwan Seo, Research Institute and Hospital, National Cancer Center, Goyang, Korea
Jin Soo Lee, Research Institute and Hospital, National Cancer Center, Goyang, Korea
Il Soon Kim, Korean Associations of Smoking and Health, Seoul, Korea
Yong-Ik Kim, Department of Health Policy and Management, Seoul National University College of Medicine, Seoul, Korea
Jong-Koo Lee, Korea Center for Disease Control and Prevention, Seoul, Korea
Dae-Kyu Oh, The Health Promotion Bureau at the Ministry of Health, Welfare, Gender Equality and Family, Seoul, Korea
Jonathan M. Samet, Department of Preventive Medicine and the USC Institute for Global Health, Keck School of Medicine, University of Southern California, USA
John P. Pierce, Sam M. Walton Professor of Cancer Research and Associate Director for Cancer Prevention and Control, UCSD Cancer Center, California, USA
David Hill, Anti-Cancer Council of Victoria, Australia
Amanda Amos, Professor of Health Promotion, UK Centre for Tobacco Control Studies, Public Health Sciences, Divison of Community Health Sciences, University of Edinburgh, Scotland, UK
Judith Mackay, Senior Advisor, World Lung Foundation, and
Director, Asian Consultancy on Tobacco Control, Kowloon, Hong Kong
Fabio Levi, Registres Vaudois et Neuchâtelois des Tumeurs, Institut universitaire de médecine
sociale et preventive, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Carlo La Vecchia, Istituto di Ricerche Farmacologiche <"Mario Negri>", Milan, Italy
Paolo Boffetta, International Agency for Research on Cancer, Lyon, France
Eva Negri, Istituto di Ricerche Farmacologiche <"Mario Negri>", Milan, Italy
Tongzhang Zheng, Associate Professor, Department of Epidemiology and Public Health, Yale School of Medicine, New Haven, USA
David Zaridze, Director, Institute of Carcinogenesis, N.N. Blokhin Russian Cancer Research Center, Moscow, Russia
Edward Giovannucci, Harvard School of Public Health, Departments of Nutrition and Epidemiology; and Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, USA
Maribel Almonte, Cancer Research UK Centre for Mathematics, Statistics and Epidemiology, Wolfson Institute of Preventive Medicine, Queen Mary University of London, Barts & The London School of Medicine and Dentistry, London, UK
Anne Szarewski, Cancer Research UK Centre for Mathematics, Statistics and Epidemiology, Wolfson Institute of Preventive Medicine, Queen Mary University of London, Barts & The London School of Medicine and Dentistry, London, UK
Jack Cuzick, Cancer Research UK Centre for Mathematics, Statistics and Epidemiology, Wolfson Institute of Preventive Medicine, Queen Mary University of London, Barts & The London School of Medicine and Dentistry, London, UK
Patrick Maisonneuve, Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
Peter Boyle, Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
Graham G. Giles, Cancer Epidemiology Centre, The Cancer Council Victoria, Australia
Areti Lagiou, Faculty of Health Professions, Athens Technological Educational Institute, Greece
Dimitrios Trichopoulos, Department of Epidemiology, Harvard School of Public Health, Boston, USA
Harvey A. Risch, Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, USA
Paul D. Terry, Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, USA
Thomas E. Rohan, Department of Epidemiology and Population Health, Albert Einstein College of Medicine, New York, USA
Elisabete Weiderpass, Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden and The Cancer Registry of Norway, Oslo, Norway
Konrad Jamrozik, Professor of Primary Care Epidemiology, Imperial College of Science, Technology and Medicine, London, UK
David M. Burns, Professor Emeritus of Family and Preventive Medicine, UCSD School of Medicine, Del Mar, USA
Allan Hackshaw, Deputy Director, Cancer Research UK & University College London Cancer Trials Centre, London, UK
Albert B. Lowenfels, Professor of Surgery, New York Medical College, USA
Richard A. Daynard, Northeastern University School of Law, Boston, USA
Ron Borland, The Cancer Council Victoria, Australia
K. Michael Cummings, Roswell Park Cancer Institute, Buffalo, USA
Nigel Gray, Honorary Senior Associate, Cancer Council Victoria, Australia
Robyn L. Richmond, School of Public Health and Community Medicine, The University of New South Wales, Kensington, Australia
Nicholas Zwar, School of Public Health and Community Medicine, The University of New South Wales, Kensington, Australia
Simon Chapman, Professor of public health, University of Sydney, Australia
Vera Luiza da Costa e Silva, Senior Public Health Consultant
Raman Minhas, Technical Officer, WHO Tobacco Free Initiative, World Health Organization, Geneva, Switzerland
Douglas Bettcher, Director, Tobacco Free Initiative, World Health Organization, Geneva, Switzerland


C. Everett Koop: Preface
Tobacco: History
1: Sir Richard Doll: Evolution of knowledge of the smoking epidemic
2: Michael J. Thun and S. J. Henley: The great studies of smoking and disease in the twentieth century
3: Lynn T. Kozlowski and Richard J. O'Connor: Dealing with health fears: Cigarette advertising in the United States in the twentieth century
4: Melanie Wakefield: Market manipulation: How the tobacco industry recruits and retains smokers
5: Channing Robertson and Richard Hurt: In Their Own Words: An epoch of deceit and deception
Tobacco: Composition
6: Ilse Hoffmann and Dieter Hoffmann: The changing cigarette: chemical studies and bioassays
7: Stephen S. Hecht: Tobacco carcinogenesis: Mechanisms and biomarkers
Nicotine and addiction
8: Jack E. Henningfield and Neal L. Benowitz: Pharmacology of tobacco addiction
9: Geoffrey Ferris Wayne and Carrie M. Carpenter: Manipulating product design to reinforce tobacco addiction
10: Mirjana V. Djordjevic: Nicotine dosing characteristics across products
Tobacco around the world
11: Witold Zatonski, Marta Manczuk: Tobacco smoking and tobacco-related harm in the European Union with the special attention to the new EU member states
12: Prakash C. Gupta and Cecily S. Ray: The epidemic in India
13: Richard Peto, Zheng-ming Chen and Jillian Boreham: The epidemic in China
14: Jae-Gahb Park, Ji Won Park, Hong-Gwan Seo, Jin Soo Lee, Il Soon Kim, Yong-Ik Kim, Jong-Koo Lee and Dae-Kyu Oh: Tobacco Control in Korea
Tobacco and health. Global burden
15: Richard Peto: The hazards of smoking and the benefits of stopping: Cancer mortality and overall mortality
16: Jonathan M. Samet: Passive smoking and health
17: John P. Pierce, Janet M Distefan and David Hill: Adolescent smoking
18: Amanda Amos and Judith Mackay: Tobacco and women
Tobacco and cancer
19: Fabio Levi and Carlo La Vecchia: Cancer of the prostate
20: Paolo Boffetta: Laryngeal cancer
21: Eva Negri: Smoking and cancer of the oesophagus
22: Tongzhang Zheng: Tobacco use and cancer of the oral cavity
23: David Zaridze: Smoking and stomach cancer
24: E. Giovanucci: Tobacco and colorectal cancer
25: Jack Cuzick, Maribel Almonte and Anne Szarewski: Tobacco and cervical neoplasia
26: Patrick Maisonneuve: Smoking and pancreatic cancer
27: Peter Boyle and Graham Giles: Smoking and lung cancer
28: Areti Lagiou and Dimitrios Trichopoulos: Active and passive smoking and cancer of the breast
29: Crystal N. Holick and Harvey A. Risch: Smoking and ovarian cancer
30: Paul D. Terry, Thomas E. Rohan and Elisabete Weiderpass: Smoking, hormone concentrations and ovarian cancer
Tobacco and cardiovascular disease
31: Konrad Jamrozik: Tobacco and cardiovascular disease
Tobacco and respiratory disease
32: David Burns: Chronic obstructive lung disease
33: Allan Hackshaw: Tobacco and other diseases
Tobacco and alcohol
34: Albert B. Lowenfels and Patrick Maisonneuve: Interaction of tobacco with other risk factors
Tobacco control: successes and failures
35: Richard A. Daynard: Roles of tobacco litigation in societal change
36: Maria Leon-Roux and John P. Pierce: The adoption of smoke-free policies and their effectiveness
37: Ron Borland and K. Michael Cummings: Advancing tobacco control by effective evaluation
38: Nigel Gray: Global tobacco policy
Treatment of dependence
39: Robyn L. Richmond and Nicholas Zwar: Treatment of tobacco dependence
Harm Reduction
40: Dorothy Hatsukami and Mark Parascandola: Tobacco harm reduction
Advocacy and activism in the real world
41: Simon Chapman: Influencing politicians to implement comprehensive tobacco control: the power of news media
Overview of regulatory efforts
42: Vera Luiza da Costa e Silva and Douglas Bettcher: Origins and status of the WHO framework convention on tobacco control (WHO FCTC)
43: Raman Minhas and Douglas Bettcher: WHO - Coordinating international policy in tobacco control